Skip to content
Surprising Science

A Universal Flu Vaccine Is Close

Two drug companies are testing formulations of a universal flu vaccine in hopes of bringing a successful version to market in the coming years. It could replace the annual flu shot. 

What’s the Latest Development?


Several pharmaceutical companies are getting closer to marketing a universal flu vaccine which could replace the annual autumn flu shot and prove more effective. Designing a flu vaccine is notoriously difficult because the virus can morph quickly, thus fooling the immune system. But the company BiondVax has tested a vaccine which arms the body against all strains by isolating nine characteristics that remain constant across all types of flu. In a clinical trial, the vaccine vastly outperformed the placebo vaccine. 

Smarter faster: the Big Think newsletter
Subscribe for counterintuitive, surprising, and impactful stories delivered to your inbox every Thursday

What’s the Big Idea?

Preventing the seasonal flu is one small aim of a universal flu vaccine. Flu pandemics like the H1N1 virus of 2009 have already threatened large populations and the United Nations announced in August that a new strain of the H5N1 bird flu virus is currently menacing Asia. “It’s almost inevitable that another pandemic will come,” says Dr. Antonio Lanzavecchia of the Swiss Federal Institute of Technology in Zurich. If the bird flu virus gains the capacity to spread from human to human, it could decimate the world population. 


Related

Why death matters

Reframing life in terms of death reveals some of the biggest philosophical problems with how we think about living systems.

Up Next